Ezetimibe and Ddd - a phase IV clinical study of FDA data

Summary:

Ddd is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ddd when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,819 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Ddd?

Ddd is found to be associated with 1,412 drugs and 1,390 conditions by eHealthMe. Check the latest studies of Ddd.

On Sep, 14, 2025

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 96 people (0.32%) have Ddd.

Among these 96 people:

How long have people been on Ezetimibe when they have Ddd? *

What is the gender of people who have Ddd when taking Ezetimibe? *

female: 74.39 %
male: 25.61 %

What is the age of people who have Ddd when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

What are other side effects people have besides Ddd? *

Pain: 60 people, 62.50%
Urinary Tract Infection: 45 people, 46.88%
Back Pain: 45 people, 46.88%
Weight Increased: 43 people, 44.79%
Heart Rate Increased: 43 people, 44.79%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 43 people, 44.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 41 people, 42.71%
Haemoglobin Decreased: 41 people, 42.71%
Haematocrit Decreased: 41 people, 42.71%
Blood Pressure Systolic Increased: 40 people, 41.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 32 people, 33.33%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 23 people, 23.96%
Neuroendocrine Tumor: 19 people, 19.79%
High Blood Pressure: 11 people, 11.46%
Antinuclear Antibody Positive: 10 people, 10.42%
Cardiac Failure: 7 people, 7.29%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 6.25%
Depression: 3 people, 3.12%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 3.12%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Ddd?

- Check whether Ddd is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,819 reports)

Ddd treatments and more:

Ddd (19,905 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ddd:

Ddd (1,412 drugs)

Browse all the conditions that are associated with Ddd:

Ddd (1,390 conditions)

Drugs similar to Ezetimibe and Ddd :

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.